← Companies|Arbor Bio
Ar

Arbor Bio

Ann Arbor MIFounded 201250 employees
Private CapbiotechPrivateGenetic Medicine
Platform: rAAV Cargo
Market Cap
N/A
All Drugs
2
Clinical Trials
4
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
NirafotisoranARB-1107Preclinical2VaccineSMN2Anti-TauCKDET
MotainavolisibARB-6037Phase 12Fusion ProteinCFTRIL-23iAsthmaMyelofibrosis
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (4)
2026-07-05
Motainavolisib Interim
Asthma
Interim
2026-12-04
Motainavolisib Interim
Myelofibrosis
Interim
2026-12-06
Nirafotisoran Interim
CTCL
Interim
2026-12-24
Nirafotisoran Interim
CTCL
Interim